- Clinical indications for included lung cancer patients.
| Variables | LC (n=196) | HC (n=33) |
|---|---|---|
| Age | ||
| Above 60 | 121 (61.7) | 20 (60.6) |
| Below 60 | 75 (38.3) | 13 (39.4) |
| Gender | ||
| Male | 139 (70.9) | 20 (60.6) |
| Female | 57 (29.1) | 13 (39.4) |
| T stage | ||
| 1-2 | 94 (48.0) | --- |
| 3-4 | 102 (52.0) | --- |
| Metastases | ||
| LM | ||
| Yes | 145(74.0) | --- |
| No | 51 (26.0) | --- |
| DM | ||
| Yes | 96 (48.9) | --- |
| No | 100 (51.1) | --- |
| Tumor subtype | ||
| LUAD | 70 (35.7) | --- |
| LUSC | 56 (28.6) | --- |
| SCLC | 70 (35.7) | --- |
Values are presented as numbers and percentages (%). LC: lung cancer, LUAD: lung adenocarcinoma, LUSC: lung squamous cell carcinoma, SCLC: small cell lung cancer, LM: lymphatic metastasis, DM: distant metastasis